Double-blind randomized placebo-controlled multicenter clinical trial (phase IIa) on diindolylmethane’s efficacy and safety in the treatment of CIN: implications for cervical cancer prevention

Overview of attention for article published in EPMA Journal, December 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (75th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter: 2 X users
facebook: 1 Facebook page

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 33 Mendeley

Summary X Facebook Wikipedia Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,663 followers.

Double-blind randomized placebo-controlled multicenter clinical trial (phase IIa) on diindolylmethane's efficacy… https://t.co/BXFrgBByyj

Reply Repost Favourite

Double-blind randomized placebo-controlled multicenter clinical trial (phase IIa) on diindolylmethane’s efficac... https://t.co/sEsjGLjcjq

Reply Repost Favourite